Frazier Life Sciences Public Fund, L.P.

VRDN

Frazier Life Sciences Public Fund, L.P. serves as 10% Owner at Viridian Therapeutics, Inc. (VRDN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$2.20M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$2.20M

Companies Traded

VRDN

Active Period

Sep 2021

1 total trades

Most Recent

Buy VRDN

Sep 28, 2021 · $2.20M

Frazier Life Sciences Public Fund, L.P.'s Insider Trading at Viridian Therapeutics, Inc. (VRDN)

Buys

1 · $2.20M

Sells

0 · $0.00

Total Shares Bought

200,000

Total Shares Sold

VRDN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 28, 2021	Buy	200,000	$11.00	$2.20M	1,505,200

Related Insiders

Fairmount Funds Management LLC

director, 10 percent owner:

VRDNBuy · May 13, 2026

Jennifer Tousignant

Chief Legal Officer

VRDNSell · Dec 31, 2025

Explore More Insider Trading Data

VRDN Insider Trading Activity

View all insider trades at Viridian Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity